D-Index & Metrics Best Publications
Microbiology
Germany
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 75 Citations 46,392 207 World Ranking 882 National Ranking 45

Research.com Recognitions

Awards & Achievements

2023 - Research.com Microbiology in Germany Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Virus
  • Immune system

The scientist’s investigation covers issues in Virology, Coronavirus, Virus, Proteases and Protease. In his study, Molecular biology is strongly linked to Cell culture, which falls under the umbrella field of Virology. The various areas that Stefan Pöhlmann examines in his Coronavirus study include Pandemic, Betacoronavirus and Severe acute respiratory syndrome coronavirus 2.

His work on Tissue tropism as part of general Virus study is frequently linked to Coronaviridae, bridging the gap between disciplines. His Proteases research incorporates elements of Viral entry and Transmembrane protein. His research integrates issues of Cathepsin and Orthomyxoviridae in his study of Protease.

His most cited work include:

  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (6831 citations)
  • A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. (576 citations)
  • Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response (525 citations)

What are the main themes of his work throughout his whole career to date?

Stefan Pöhlmann focuses on Virology, Virus, Viral entry, Coronavirus and Cell culture. His studies in Virology integrate themes in fields like Proteases, DC-SIGN and Antibody. His Proteases research is multidisciplinary, incorporating elements of Serine protease, Protease, Cathepsin and Transmembrane protein.

His study in the fields of Neutralization and Neutralizing antibody under the domain of Antibody overlaps with other disciplines such as Severe acute respiratory syndrome coronavirus 2. The concepts of his Viral entry study are interwoven with issues in Infectivity, Sphingosine, Immune system and Cell biology. His Coronavirus study frequently draws connections between adjacent fields such as Middle East respiratory syndrome.

He most often published in these fields:

  • Virology (96.62%)
  • Virus (42.62%)
  • Viral entry (27.85%)

What were the highlights of his more recent work (between 2018-2021)?

  • Virology (96.62%)
  • Virus (42.62%)
  • Coronavirus (23.63%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Virology, Virus, Coronavirus, Severe acute respiratory syndrome coronavirus 2 and Antibody. His Virology study combines topics from a wide range of disciplines, such as Cell culture, Protease and Immune system. His Virus research incorporates themes from Seroprevalence, In vivo and Cell biology.

His Coronavirus research is multidisciplinary, relying on both Middle East respiratory syndrome and Betacoronavirus. His research investigates the link between Antibody and topics such as Vaccination that cross with problems in Blockade and Recombinant DNA. His study in Viral entry is interdisciplinary in nature, drawing from both Ex vivo, Proteases, Sphingosine, Sphingolipid and Ebola virus.

Between 2018 and 2021, his most popular works were:

  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (6831 citations)
  • A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. (576 citations)
  • The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells (369 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Immune system

His primary areas of investigation include Virology, Coronavirus, Antibody, Neutralization and Severe acute respiratory syndrome coronavirus 2. His Virology study integrates concerns from other disciplines, such as Cell culture and Receptor. His work carried out in the field of Receptor brings together such families of science as Serine protease and Priming.

His study brings together the fields of Middle East respiratory syndrome and Coronavirus. His studies deal with areas such as Blockade, Recombinant DNA and Vaccination as well as Antibody. His Neutralization study incorporates themes from Cell and Vesicular stomatitis virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann;Hannah Kleine-Weber;Simon Schroeder;Nadine Krüger.
Cell (2020)

22581 Citations

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.

Markus Hoffmann;Hannah Kleine-Weber;Stefan Pöhlmann.
Molecular Cell (2020)

1684 Citations

Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

Ilona Glowacka;Stephanie Bertram;Marcel A. Müller;Paul Allen.
Journal of Virology (2011)

965 Citations

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Heike Hofmann;Krzysztof Pyrc;Lia van der Hoek;Martina Geier.
Proceedings of the National Academy of Sciences of the United States of America (2005)

776 Citations

TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.

Adeline Heurich;Heike Hofmann-Winkler;Stefanie Gierer;Thomas Liepold.
Journal of Virology (2014)

732 Citations

Diversity of receptors binding HIV on dendritic cell subsets

Stuart G. Turville;Paul U. Cameron;Amanda Handley;George Lin.
Nature Immunology (2002)

660 Citations

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Hoffmann M;Kleine-Weber H;Krüger N;Müller M.
bioRxiv (2020)

584 Citations

Protease inhibitors targeting coronavirus and filovirus entry

Yanchen Zhou;Punitha Vedantham;Kai Lu;Juliet Agudelo.
Antiviral Research (2015)

548 Citations

Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

Stefan Pöhlmann;Jie Zhang;Frédéric Baribaud;Zhiwei Chen.
Journal of Virology (2003)

531 Citations

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

Jacqueline D. Reeves;Stephen A. Gallo;Navid Ahmad;John L. Miamidian.
Proceedings of the National Academy of Sciences of the United States of America (2002)

530 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefan Pöhlmann

Shibo Jiang

Shibo Jiang

Fudan University

Publications: 94

Steve P. Watson

Steve P. Watson

University of Birmingham

Publications: 67

Gary R. Whittaker

Gary R. Whittaker

Cornell University

Publications: 58

Ralph S. Baric

Ralph S. Baric

University of North Carolina at Chapel Hill

Publications: 57

Christian Drosten

Christian Drosten

Charité - University Medicine Berlin

Publications: 57

Kwok-Yung Yuen

Kwok-Yung Yuen

University of Hong Kong

Publications: 56

Robert W. Doms

Robert W. Doms

Children's Hospital of Philadelphia

Publications: 56

Andrés Finzi

Andrés Finzi

University of Montreal

Publications: 51

Marcel A. Müller

Marcel A. Müller

Charité - University Medicine Berlin

Publications: 48

Frank Kirchhoff

Frank Kirchhoff

University of Ulm

Publications: 47

Yvette van Kooyk

Yvette van Kooyk

Vrije Universiteit Amsterdam

Publications: 43

Olivier Schwartz

Olivier Schwartz

Université Paris Cité

Publications: 42

Heinz Feldmann

Heinz Feldmann

National Institutes of Health

Publications: 41

Jan Münch

Jan Münch

University of Ulm

Publications: 40

Kartik Chandran

Kartik Chandran

Albert Einstein College of Medicine

Publications: 38

Michael Farzan

Michael Farzan

University of Florida

Publications: 38

Trending Scientists

Peter Händel

Peter Händel

Royal Institute of Technology

Amos Storkey

Amos Storkey

University of Edinburgh

Robert L. Jernigan

Robert L. Jernigan

Iowa State University

Ingo Dreyer

Ingo Dreyer

University of Talca

Stephen Hughes

Stephen Hughes

Queen's University

Stephanie A. Henson

Stephanie A. Henson

National Oceanography Centre

Silvio Mollo

Silvio Mollo

Sapienza University of Rome

Alex Sen Gupta

Alex Sen Gupta

University of New South Wales

Zuner A. Bortolotto

Zuner A. Bortolotto

University of Bristol

Dario Grossi

Dario Grossi

University of Campania "Luigi Vanvitelli"

Antony Basten

Antony Basten

Garvan Institute of Medical Research

David F. Kallmes

David F. Kallmes

Mayo Clinic

Robert C. Baxter

Robert C. Baxter

Royal North Shore Hospital

John B. West

John B. West

University of California, San Diego

Jan Claassen

Jan Claassen

Columbia University

Toshikazu Onishi

Toshikazu Onishi

Osaka Metropolitan University

Something went wrong. Please try again later.